A Director at Corporate Office Properties (NYSE: OFC) is Buying Shares

By Carrie Williams

Today, a Director at Corporate Office Properties (OFCResearch Report), Taylor Pickett, bought shares of OFC for $231.9K.

Following this transaction Taylor Pickett’s holding in the company was increased by 37.06% to a total of $860.3K. Following Taylor Pickett’s last OFC Buy transaction on December 17, 2013, the stock climbed by 5.9%.

See today’s analyst top recommended stocks >>

The company has a one-year high of $30.57 and a one-year low of $15.23. Currently, Corporate Office Properties has an average volume of 31.21K. OFC’s market cap is $2.61 billion and the company has a P/E ratio of 23.50.

Based on 4 analyst ratings, the analyst consensus is Moderate Buy with an average price target of $29.67, reflecting a -20.7% downside.

In the last 30 days, insiders have sold $86.16K worth of OFC shares and purchased $231.9K worth of OFC shares. The insider sentiment on Corporate Office Properties has been negative according to 34 insider trades in the past three months. This sentiment is lower than the average sentiment of company insiders in this sector.

Company insider trades are published daily on the SEC (Securities and Exchange Commission). DailyInsider’s proprietary algorithm analyzes these trades and selects the most attractive stocks based on influential insider trades each day. To subscribe to the DailyInsider visit this page.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Corporate Office Properties Trust, Inc. is a real estate investment trust, which acquires, develops, manages, sells, and leases out office properties and data centers. The firm operates through the following segments: Defense/Information Technology Locations, Regional Office, Wholesale Data Center, and Other. The company was founded in 1988 and is headquartered in Columbia, MD.